It has been reported that the direct interaction of WNT7a ligand and its receptor FZD9 repressed cell growth and promoted cell differentiation in NSCLC, indicating an antitumor effect of WNT7a and FZD9 in human cancers [74,75]. This evidence concerns the gene WNT7A and cancer.